Issue 369 | September 12, 2017

Latest News: Spotlight One
Hollin: Value Assessment Frameworks Should Represent a Spectrum of Patient Preferences

Health Economist: Public Should Have Role in Drug Pricing

Report: Big Pharma Company Helped Fuel Opioid Epidemic

Could DACA’s End Lead to Public Health Crisis?

Medicaid Could Help Address Social Determinants of Health

Editorial: When It Comes to the Drug Pricing Debate, Talk Is Cheap

California Senate Could Vote on Drug Transparency Bill

The Journey to Value

How Can a New Value Framework Impact Orphan Drug Woes?

Departing Novartis CEO Eyes Silicon Valley; What Next?

Spotlight Two
Special thanks to our partners:
Conference of the Week Webinar of the Week Latest Jobs

Associate Director of Value Strategy and Communications

Health Economist

Research Associate I/II - Health Preferences

Research Scientist - Outcomes Research/Health Preferences

Senior Research Associate – Modeling and Simulation - Health Economics

Pricing and Market Access Associate Director

Director/Senior Director, HEOR, HE Modeling

Link of the Week Job of the Week
Upcoming Conferences Upcoming Webinars
9th Semi-Annual Managed Markets and Account Management Strategies Conference
September 14-15
Chicago, Illinois

ISPOR 6th Latin America Conference
September 15-17
Sao Paulo, Brazil

ACO Leadership and Strategic Governance Forum
September 18-19
Dallas, Texas

Social Media: A Rich Data Source or a Can of Worms? A Guide to the Use of Health-Related Social Media in the Pharmaceutical Industry
September 13

Estimating Health-State Utility for Economic Models in Clinical Studies
September 14

Big Data and Cognitive Computing: The Next Generation of RWE for Rheumatologic and Related Immunologic Disorders
September 20


Xcendaeyeforpharma eMaxHealth Evidera Curo Jefferson HealthCoreTruven Doctor Evidence Quintiles IMS Humana OM1 Parexel Evidence Partners DRG Abacus MAPS G&J Lee Recruitment